,
6 tweets,
2 min read
Read on Twitter
We got "capture stating" w/Guptas in S Africa, managing a billion dollar secret fund, violating COIs of bankruptcy proceedings, advising MBS/Yanukovich, consulting Boeing on aluminum by bribing Indian officials & how to work w/Firtash.
And now THIS ⬇️:
nytimes.com/2019/07/25/bus…
And now THIS ⬇️:
nytimes.com/2019/07/25/bus…
One lawsuit revealed McKinsey recommending that a pharmaceutical company “get more patients on higher doses of opioids” and study techniques “for keeping patients on opioids longer.”
Although McKinsey is not a defendant, Oklahoma used McKinsey consulting records to help build its case against Johnson & Johnson and a subsidiary, Janssen Pharmaceuticals, for what the state said was irresponsible marketing of a fentanyl patch called Duragesic.
Massachusetts released new docs from 2013 that detailed McKinsey’s recommendations on how Purdue Pharma could “turbocharge” sales of OxyContin. McKinsey advised Purdue to sharply increase sales visits to targeted doctors & to consider mail orders as a way to bypass pharmacies.
The trial introduced a PPT prepared by McKinsey for Johnson & Johnson in 2002 that raised the issue of whether the company had been sufficiently aggressive enough. In one slide, McKinsey asked, “Are we properly targeting & influencing prescription behavior in pain clinics?”
McKinsey also recommended “targeting & influencing” doctors who specifically treat back pain in THE ELDERLY & those in LONG-TERM CARE. They also advised to move physicians who were “stuck” in prescribing less potent opioids into prescribing STRONGER formulations.
